Introducion
Estimation of pneumonia and influenza mortality excess based on forecasting methods has been performed on a routine basis for 25 years in the United States.1 However, morbidity excess linked to influenza epidemics in the community has never been assessed; the French Communicable Diseases Computer Network (FCDN) provides a unique opportunity to study the feasibility of such forecasts and to measure the impact of such an epidemic in terms of the number of cases and the cost of sick leave.
Methods

Influenza-like Syndrome and the FCDN
The initial version of the FCDN has been previously described in detail. 
Biscussion
This simple tool has demonstrated its efficacy within our data set. The method was used to forecast the 1989-90 nonepidemic level of influenza-like syndrome and to notify the medical community when the epidemic began (during the last week of November 1989). It was also useful in assessing the public health impact of influenza-like syndrome in France.
Until now, only mortality data have been used to forecast non-epidemic patterns. Several problems are worth noting with mortality data.6 In addition to delay in reporting, there is a lag between the increase in the number of cases of influenza-like syndrome and the increase in the number of deaths attributed to pneumonia and influenza. Furthermore, some epidemics can escape detection, if associated with insignificant mortality excess, e.g. when few people 65 years of age and older are attacked by the epidemic. Mortality data only allow the quantification the mortality excess.
Hospital morbidity data have also been used to assess the cost, but reflect only the most severe cases.7 Morbidity data collected on line from SGPs have allowed both a rapid detection of an epi-demic and the quantification of the impact of such an epidemic in terms of sick leave.
The development of tools, currently in progress, will permit the use of the same method on a regional basis. The tool described here, in association with other methods developed at our center8 will allow the prospective prediction of future epidemics and assessments oftheir economic impact with reasonable accuracy. [ Introdution Antibiotics are commonly used and can be obtained without prescription in many developing countries.1 Although antibiotics are valuable treatments of many infectious diseases, they are not without risk. Potential problems associated with their use include the selection of resistant bacteria2 and the development of serious side effects, including antibiotic-associated diarrhea.3 Furthermore, the use of antibiotics has been documented to predispose to symptomatic Salbonella gastroenteritis. 4 We therefore hypothesized that antibiotic use might be a risk factor for diarrhea among a cohort of children in a community settingwhere the likelihood of exposure to infection was high.
Meods
This study was part of an illness surveillance project5 undertaken from 1984 to 1986 in a three block area of a slum in the northeastern Brazilian city of Fortaleza, which has a population of nearly two million. Thrice weekly visits were made by trained community health workers to the homes of a cohort of children less than five years of age. At each visit, a history of any diarrhea since the previous visit was obtained from the caretaker of each child. Diarrhea was defined as an increase in stool frequency or decrease in consistency as noted by the caretaker. At least three diarrhea-free days separated episodes.
Antibiotic use was determined over a 16-week period (January-April 1986) by weekly visits by one of the authors (JBS) to each ofthe 45 homes of the 105 children enrolled in the cohort at the time. A standardized questionnaire was employed to obtain information concerning antibiotics used by the children during the previous week. An antibiotic course was defined as one or more doses of a drug, given at least daily with less than two days interruption.
